DNA vaccination has proved to be a generally applicable technology in various preclinical animal models of infectious and noninfectious disease and several DNA vaccines have now entered phase I human clinical trials. It is too early to predict the effectiveness of DNA vaccines in humans and whether
β¦ LIBER β¦
DNA fusion vaccines enter the clinic
β Scribed by Freda K. Stevenson; Ann Mander; Lindsey Chudley; Christian H. Ottensmeier
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 379 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Toward the development of DNA vaccines
β
Jeffrey B Ulmer; John J Donnelly; Margaret A Liu
π
Article
π
1996
π
Elsevier Science
π
English
β 631 KB
FK-506 enters the clinic
β
Angus W. Thomson
π
Article
π
1990
π
Elsevier Science
π
English
β 347 KB
New vaccines against hepatitis a enter t
β
S. Iwarson
π
Article
π
1992
π
Springer-Verlag
π
English
β 299 KB
The role of CpG in DNA vaccines
β
McCluskie, Michael J. ;Weeratna, Risini D. ;Davis, Heather L.
π
Article
π
2000
π
Springer
π
English
β 539 KB
DNA microarrays in the clinic: infectiou
β
Vladimir Mikhailovich; Dmitry Gryadunov; Alexander Kolchinsky; Alexander A. Maka
π
Article
π
2008
π
John Wiley and Sons
π
English
β 319 KB
π 1 views
## Abstract We argue that the mostβpromising area of clinical application of microarrays in the foreseeable future is the diagnostics and monitoring of infectious diseases. Microarrays for the detection and characterization of human pathogens have already found their way into clinical practice in s
DNA fusion gene vaccination mobilizes ef
β
Jason Rice; MichelleβL. Dossett; Claes ΓhlΓ©n; SarahβL. Buchan; TimothyβJ. Kendal
π
Article
π
2008
π
John Wiley and Sons
π
English
β 401 KB